azoxymethane has been researched along with Benign Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Horinaka, M; Ishikawa, H; Masuda, M; Morita, M; Mutoh, M; Nishimoto, E; Sakai, T; Yasuda, S | 1 |
| Chu, Y; Gu, J; Huang, E; Li, Y; Liang, Y; Liu, J; Liu, R; Lu, Z; Wang, L; Wang, Z; Yu, H; Zhang, D; Zhang, H | 1 |
| Gao, Y; Guo, QL; Guo, XK; Hu, R; Jia, JM; Jiang, JW; Jiang, ZY; Sun, HP; Sun, ZY; Tao, L; Wang, YJ; Xi, MY; Xu, LL; Xu, XL; Xue, X; Yang, X; Ye, M; You, QD; Zhang, MY; Zhang, XJ; Zhu, JF | 1 |
| Furuta, M; Ikezumi, M; Izumi, K; Kawakami, K; Matsumoto, H; Negishi, S; Ohta, R; Sasaki, K; Sui, H; Takahashi, T; Takashi, K; Todoriki, S; Toyoizumi, T; Yamakage, K | 1 |
| Ananda Sadagopan, SK; Ismail, A; Mohd Esa, N; Mustafa, MR; Pandurangan, AK; Saadatdoust, Z | 1 |
| Bai, LP; Chan, KM; Chan, RW; Dong, H; Guo, J; Guo, Y; Hsiao, WW; Jiang, ZH; Kam, RK; Kong, AN; Law, BY; Leung, EL; Liang, X; Liu, L; Wang, J; Wang, R; Wong, VK; Yen, FG; Yu, Z; Zhang, W; Zhou, H | 1 |
| Choi, KS; Chung, MH; Hahm, KB; Han, YM; Hong, H; Hong, KS; Kim, EH; Ock, CY | 1 |
| Behan, NA; Brooks, SP; Caldwell, D; Green, J; MacFarlane, AJ; Matias, FM | 1 |
| Agis-Torres, A; Bravo, L; Goya, L; López-Oliva, E; Martín, MA; Ramos, S; Rodríguez-Ramiro, I | 1 |
| Andraos, R; Cheong, R; Feinberg, AP; Iacobuzio-Donahue, CA; Kaneda, A; Ko, MS; Levchenko, A; Longo, DL; Ohlsson, R; Onyango, P; Pearson, MA; Sharov, AA; Timp, W; Wang, CJ; Wen, B | 1 |
| Bailey, G; Casto, B; Pereira, C; Ralston, S; Roebuck, B; Stoner, G | 1 |
| Ward, JM | 1 |
| Kroes, R; Weisburger, JH; Weiss, JW | 1 |
1 review(s) available for azoxymethane and Benign Neoplasms
| Article | Year |
|---|---|
Immune suppression and chemical carcinogenesis.
Topics: Animals; Antilymphocyte Serum; Azoxymethane; B-Lymphocytes; Carcinogens; Cocarcinogenesis; Cricetinae; Hydroxyacetylaminofluorene; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mice; Neoplasms; Neoplasms, Experimental; Rats; T-Lymphocytes; Thymus Gland; Time Factors | 1975 |
12 other study(ies) available for azoxymethane and Benign Neoplasms
| Article | Year |
|---|---|
Discovery of cancer-preventive juices reactivating RB functions.
Topics: Animals; Antioxidants; Apoptosis; Azoxymethane; Carcinogenesis; Humans; Neoplasms; Rats | 2023 |
Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1.
Topics: Adenocarcinoma; Aged; Animals; Azoxymethane; B-Lymphocytes; Cells, Cultured; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Glucose; Humans; Immunoglobulin G; Lung Neoplasms; Male; Matrix Attachment Region Binding Proteins; Mice; Mice, Inbred C57BL; Neoplasms; Promoter Regions, Genetic; RNA, Small Interfering; STAT6 Transcription Factor | 2019 |
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
Topics: Active Transport, Cell Nucleus; Adenoma; Animals; Antineoplastic Agents; Antioxidant Response Elements; Azoxymethane; Blotting, Western; Cell Nucleus; Colorectal Neoplasms; Dextran Sulfate; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heme Oxygenase-1; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred C57BL; Models, Chemical; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Neoplasms; NF-E2-Related Factor 2 | 2013 |
Genotoxic potential and in vitro tumour-promoting potential of 2-dodecylcyclobutanone and 2-tetradecylcyclobutanone, two radiolytic products of fatty acids.
Topics: Animals; Azoxymethane; Carcinogens; Cell Line; Chromosome Aberrations; Colon; Comet Assay; Cricetinae; Cyclobutanes; DNA Damage; Dose-Response Relationship, Drug; Fatty Acids; Female; Food Irradiation; Male; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagenicity Tests; Mutagens; Neoplasms; Rats; Rats, Sprague-Dawley; Salmonella typhimurium | 2014 |
Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Azoxymethane; bcl-2-Associated X Protein; bcl-X Protein; Cacao; Caspase 3; Colitis; Colorectal Neoplasms; Dextran Sulfate; Diet; Epithelial Cells; Female; Gene Expression Regulation; Inflammatory Bowel Diseases; Interleukin-6; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Neoplasms; Peroxidase; Polyphenols; Signal Transduction; STAT3 Transcription Factor | 2015 |
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
Topics: Animals; Apoptosis; Azoxymethane; Carcinoma, Lewis Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dextran Sulfate; Drugs, Chinese Herbal; Energy Metabolism; Ginsenosides; Humans; Immunoblotting; Mice, Inbred C57BL; Mitochondrial Proteins; Molecular Structure; Neoplasms; Proteomics; S Phase Cell Cycle Checkpoints | 2016 |
Prevention of colitis-associated colorectal cancer with 8-hydroxydeoxyguanosine.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Azoxymethane; Colitis; Colorectal Neoplasms; Deoxyguanosine; Dextrans; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; STAT3 Transcription Factor; Sulfates | 2011 |
Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane-dextran sodium sulphate-treated mice.
Topics: Animals; Azoxymethane; Biomarkers; Colitis, Ulcerative; Colon; Colonic Neoplasms; Dextran Sulfate; Dextrans; Diet; Disease Progression; Folic Acid; Inflammation; Male; Mice; Mice, Inbred C57BL; Microbiota; Neoplasms; RNA, Ribosomal, 16S; Sulfates | 2013 |
Cocoa polyphenols prevent inflammation in the colon of azoxymethane-treated rats and in TNF-α-stimulated Caco-2 cells.
Topics: Animals; Anti-Inflammatory Agents; Azoxymethane; Biomarkers; Cacao; Colon; Diet; Down-Regulation; Humans; Inflammation; Inflammation Mediators; Male; MAP Kinase Kinase 4; Neoplasms; NF-kappa B; Phosphorylation; Phytotherapy; Plant Extracts; Polyphenols; Rats; Rats, Wistar; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genomic Imprinting; Insulin-Like Growth Factor II; Mice; Mice, Inbred C57BL; Neoplasms; Oligonucleotide Array Sequence Analysis; Pyrimidines; Pyrroles; Signal Transduction | 2007 |
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aflatoxin B1; Animals; Anticarcinogenic Agents; Azoxymethane; Body Weight; Carcinogens; Colonic Neoplasms; Disease Models, Animal; Female; Indoles; Liver; Liver Neoplasms; Mammary Neoplasms, Experimental; Mutagens; Neoplasms; Rats; Rats, Sprague-Dawley; Time Factors | 2002 |
Dose response to a single injection of azoxymethane in rats. Induction of tumors in the gastrointestinal tract, auditory sebaceous glands, kidney, liver and preputial gland.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Animals; Azo Compounds; Azoxymethane; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Duodenal Neoplasms; Duodenum; Ear Canal; Hyperplasia; Intestinal Polyps; Kidney; Kidney Neoplasms; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasms; Rats; Rodent Diseases; Sebaceous Gland Neoplasms | 1975 |